70 related articles for article (PubMed ID: 31696204)
1. CXCR3 from chemokine receptor family correlates with immune infiltration and predicts poor survival in osteosarcoma.
Tang Y; Gu Z; Fu Y; Wang J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31696204
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
Müller FS; Aherrahrou Z; Grasshoff H; Heidorn MW; Humrich JY; Johanson L; Aherrahrou R; Reinberger T; Schulz A; Ten Cate V; Robles AP; Koeck T; Rapp S; Lange T; Brachaczek L; Luebber F; Erdmann J; Heidecke H; Schulze-Forster K; Dechend R; Lackner KJ; Pfeiffer N; Ghaemi Kerahrodi J; Tüscher O; Schwarting A; Strauch K; Münzel T; Prochaska JH; Riemekasten G; Wild PS
Eur Heart J; 2023 Dec; 44(47):4935-4949. PubMed ID: 37941454
[TBL] [Abstract][Full Text] [Related]
3. Research progress of CXCR3 inhibitors.
Yuan Z
Anticancer Drugs; 2024 Jan; 35(1):36-45. PubMed ID: 37694856
[TBL] [Abstract][Full Text] [Related]
4. Targeting anti-CXCR3 autoantibodies as potential cardioprotective therapy: promises and challenges.
Tang WHW
Eur Heart J; 2023 Dec; 44(47):4950-4952. PubMed ID: 37944029
[No Abstract] [Full Text] [Related]
5. The Clinical Role of CXCR4-Targeted PET on Lymphoproliferative Disorders: A Systematic Review.
Zamanian M; Albano D; Treglia G; Rizzo A; Abedi I
J Clin Med; 2024 May; 13(10):. PubMed ID: 38792485
[No Abstract] [Full Text] [Related]
6. Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells.
Todosenko N; Yurova K; Khaziakhmatova O; Malashchenko V; Khlusov I; Litvinova L
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297616
[TBL] [Abstract][Full Text] [Related]
7. Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma.
Yang J; Zhang J; Na S; Wang Z; Li H; Su Y; Ji L; Tang X; Yang J; Xu L
Front Immunol; 2022; 13():994034. PubMed ID: 36225939
[TBL] [Abstract][Full Text] [Related]
8. A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity.
Liu B; Feng C; Liu Z; Tu C; Li Z
Front Pharmacol; 2022; 13():944158. PubMed ID: 36105232
[No Abstract] [Full Text] [Related]
9. Exosome-derived lnc-HOXB8-1:2 induces tumor-associated macrophage infiltration to promote neuroendocrine differentiated colorectal cancer progression by sponging hsa-miR-6825-5p.
Li X; Lan Q; Lai W; Wu H; Xu H; Fang K; Chu Z; Zeng Y
BMC Cancer; 2022 Aug; 22(1):928. PubMed ID: 36030223
[TBL] [Abstract][Full Text] [Related]
10. Cytokine Receptors-Regulators of Antimycobacterial Immune Response.
Druszczyńska M; Godkowicz M; Kulesza J; Wawrocki S; Fol M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163035
[TBL] [Abstract][Full Text] [Related]
11. Identification of a 7-mRNA signature as a prognostic biomarker in pediatric osteosarcoma.
Cui T; Guo J; Jin C
Transl Cancer Res; 2020 Nov; 9(11):6733-6742. PubMed ID: 35117283
[TBL] [Abstract][Full Text] [Related]
12. Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies.
Cannon A; Thompson CM; Bhatia R; Kandy RRK; Solheim JC; Batra SK; Kumar S
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188628. PubMed ID: 34560199
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study.
Chen B; Zeng Y; Liu B; Lu G; Xiang Z; Chen J; Yu Y; Zuo Z; Lin Y; Ma J
Front Endocrinol (Lausanne); 2021; 12():672024. PubMed ID: 34393996
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics integrated analysis to investigate candidate biomarkers and associated metabolites in osteosarcoma.
Wang J; Gong M; Xiong Z; Zhao Y; Xing D
J Orthop Surg Res; 2021 Jul; 16(1):432. PubMed ID: 34225733
[TBL] [Abstract][Full Text] [Related]
15. Immune status changing helps diagnose osteoarticular tuberculosis.
Liang T; Chen J; Xu G; Zhang Z; Xue J; Zeng H; Jiang J; Chen T; Qin Z; Li H; Ye Z; Nie Y; Liu C; Zhan X
PLoS One; 2021; 16(6):e0252875. PubMed ID: 34129634
[TBL] [Abstract][Full Text] [Related]
16. Immune classification of osteosarcoma.
Le T; Su S; Shahriyari L
Math Biosci Eng; 2021 Feb; 18(2):1879-1897. PubMed ID: 33757216
[TBL] [Abstract][Full Text] [Related]
17. Gene signatures with predictive and prognostic survival values in human osteosarcoma.
Qiu Z; Du X; Chen K; Dai Y; Wang S; Xiao J; Li G
PeerJ; 2021; 9():e10633. PubMed ID: 33520450
[TBL] [Abstract][Full Text] [Related]
18. Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.
Ayers J; Milner RJ; Cortés-Hinojosa G; Riva A; Bechtel S; Sahay B; Cascio M; Lejeune A; Shiomitsu K; Souza C; Hernandez O; Salute M
J Vet Diagn Invest; 2021 Mar; 33(2):261-278. PubMed ID: 33446089
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel immune-related genes prognostic signature for osteosarcoma.
Wu ZL; Deng YJ; Zhang GZ; Ren EH; Yuan WH; Xie QQ
Sci Rep; 2020 Oct; 10(1):18402. PubMed ID: 33110201
[TBL] [Abstract][Full Text] [Related]
20. Development of a prognostic gene signature based on an immunogenomic infiltration analysis of osteosarcoma.
Yu Y; Zhang H; Ren T; Huang Y; Liang X; Wang W; Niu J; Han Y; Guo W
J Cell Mol Med; 2020 Oct; 24(19):11230-11242. PubMed ID: 32820615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
